Status: current, Defined. Date: 31-Jan 2009. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711980018 | Product containing sulfacetamide in vaginal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3711981019 | Sulfacetamide-containing product in vaginal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sulfacetamide-containing product in vaginal dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Sulfacetamide-containing product in vaginal dose form | Is a | Sulfacetamide-containing product | true | Inferred relationship | Some | ||
| Sulfacetamide-containing product in vaginal dose form | Has active ingredient | Sulfacetamide | true | Inferred relationship | Some | 1 | |
| Sulfacetamide-containing product in vaginal dose form | Has manufactured dose form | Vaginal dose form | true | Inferred relationship | Some | ||
| Sulfacetamide-containing product in vaginal dose form | Is a | Product manufactured as vaginal dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sulfacetamide only product in vaginal dose form | Is a | True | Sulfacetamide-containing product in vaginal dose form | Inferred relationship | Some | |
| Sulfabenzamide- and sulfacetamide- and sulfathiazole-containing product in vaginal dose form | Is a | True | Sulfacetamide-containing product in vaginal dose form | Inferred relationship | Some | |
| Sulfabenzamide- and sulfacetamide- and sulfathiazole-containing product | Is a | False | Sulfacetamide-containing product in vaginal dose form | Inferred relationship | Some | |
| Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | Is a | False | Sulfacetamide-containing product in vaginal dose form | Inferred relationship | Some | |
| Sulfabenzamide+sulfacetamide+sulfathiazole 3.7%/2.86%/3.42% vaginal cream | Is a | False | Sulfacetamide-containing product in vaginal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR